Amphotin-lip
Composition
Lipid Complex Amphotericin B10mg / 25mg / 50mg / 100mg Vials
Pharmaceutical form
VialsTherapeutic Indications
Visceral leishmaniasisAspergillosis
Candidiasis
Cryptococcal meningitis
Fungal infection in febrile neutropenia
Posology and method of administration
The recommended initial dose of Amphotin-Lip for each indication for adult and pediatric patients is as follows :Indication Dose
(mg/kg/day)
Empirical therapy 3
Systemic fungal infections: 3-5
Aspergillus 3-5
Candida 3-5
Cryptococcus 3-5
Cryptococcal meningitis in HIV infected
patients 5
Doses recommended for visceral leishmaniasis are presented below:
Visceral Leishmaniasis Dose (mg/kg/day)
Immunocompetent patients 3.0 (days 1-5) and
3.0 on days 14, 21
Immunocompromised patients 4.0 (days 1-5) and 4.0
on days 10, 17, 24, 31, 38
Special warnings and precautions for use
Not AvailableInteraction with other pharmaceuticals
Not AvailablePregnancy and lactation
Not AvailableEffects on abilities
Not AvailableOverdose
Not AvailablePharmacological Properties
Not AvailableExcipients
Not AvailableShelf life
Not AvailableStorage
Not AvailablePackaging
1 Vial of 10mg1 Vial of 25mg
1 Vial of 50mg
1 Vial of 100mg